New generation antiplatelet therapies to prevent preeclampsia [ 2017 - 2019 ]

Research Grant

Researchers: Dr Natalie Hannan (Principal investigator) ,  Dr Tu'Uhevaha Kaitu'U-Lino ,  Prof Stephen Tong

Brief description Preeclampsia, a major complication of pregnancy, affects around 3-8% of pregnancies. Sadly, there is no way to prevent or delay disease. We have uncovered antiplatelet agents, used to prevent heart disease and stroke, may provide health benefits to women at risk of developing preeclampsia. We will test whether these agents can prevent the pathophysiology of preeclampsia in specialized human & mouse models developed in our laboratory. This work may provide a prevention strategy for preeclampsia.

Funding Amount $AUD 494,879.42

Funding Scheme Project Grants

Notes Standard Project Grant